- contact@scirent.com
- +49 30 403688333+49
Hans-Dirk Duengen PhD, MD, MBA
SCIRENT CEO and Scientific Director
Hans-Dirk Duengen is the founder and CEO of SCIRENT. He has collected a wealth of national and international experience in initiating and executing clinical trials as a senior cardiologist at the Charité University Hospital Berlin. Also, he is the author of numerous scientific publications.
Elvis Tahirovic, MBA, MPH
SCIRENT CEO and Managing Director
Elvis Tahirovic is a Co-founder and Managing Director at SCIRENT. He has more than 15 years of experience as a global project manager in the healthcare sector. He is responsible for the company’s business strategy and finances.
SCIRENT is a specialty CRO focused on cardiovascular research. We offer an excellent network of high-performing trial sites in Europe, regulatory consulting, as well as strong medical expertise in support of the design and execution of your programs
SCIRENT Patient recruitment experience & access
Heart Failure
(Including HFrEF, HFpEF and ADHF)
Chronic Myocarditis
Dilative and Hypertrophic Cardiomyopathy
Valvular Disease
Lipid disorders & Hypertension
Pulmonary Arterial Hypertension
Acute Ischemic Stroke
Atherosclerosis & CAD
Specialisation
>
1
%
Cardiovascular studies in a wide range of Patient profiles
Countries
1
+
Across Europe
Experience
1
yrs
Average experience in CV research of our team members
Focus
1
%
of the trials we conduct are in early phase development
Management
Leadership
Jovan Veskovic, MPH, Dipl. Ecc
SCIRENT CFO and Director Eastern Europe
Jovan Veskovic is a Co-Founder and the Regional Director Eastern Europe at SCIRENT. Since the beginning, he brings in his know-how and passion for managing global clinical trials. He is a management executive with degrees in Public Health and Economics.
Maximilian Posch, MD, MPH
SCIRENT Chief Medical Officer
Maximilian Posch has a strong background in academic and industry-driven research. As a clinician of internal medicine and clinical pharmacology, he has profound expertise in early phase clinical trials and cardiovascular research. In his career, he conducted more than 200 trials and co-authored numerous peer-reviewed publications.
Book a meeting with our team
* required
If you have any problems with the form above, please get in touch with us directly: contact@scirent.com